727 filings
Page 10 of 37
425
2oqy2r9g9t
26 Oct 22
Business combination disclosure
5:17pm
8-K
9cz1n4l55 7vjy18
26 Oct 22
Regulation FD Disclosure
5:14pm
425
o124 5mdiqe61
26 Oct 22
Business combination disclosure
5:10pm
8-K
a7a2be
26 Oct 22
Regulation FD Disclosure
5:08pm
425
d1yueq2qy2c5 q3
24 Oct 22
Business combination disclosure
8:00am
8-K
gwgf8 a9ds6
24 Oct 22
Entry into a Material Definitive Agreement
7:59am
CORRESP
r5sa037ixrpsn4elx
24 Oct 22
Correspondence with SEC
12:00am
425
kqkd385snx iwqen05
17 Oct 22
Business combination disclosure
4:03pm
8-K
rqj1dv63 ef7p
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm
UPLOAD
mkm qvzp54
14 Oct 22
Letter from SEC
12:00am
425
r6oeisg6q
13 Oct 22
Business combination disclosure
4:03pm
8-K
kb0s sxf5r7dd
13 Oct 22
Kineta to Present Anti-CD27 Agonist Preclinical Program at AACR Conference on Tumor Immunology and Immunotherapy
4:01pm
425
rc56iow9
11 Oct 22
Business combination disclosure
8:02am
8-K
gr6 f9ivsko0s
11 Oct 22
Kineta Announces Participation in Upcoming October 2022 Investor Conferences
8:00am
425
r72 dr62npoz05318
4 Oct 22
Business combination disclosure
4:04pm
8-K
t20tr42rusf
4 Oct 22
Kineta Appoints Keith Baker as Chief Financial Officer
4:01pm
CORRESP
6wh9dxom7
3 Oct 22
Correspondence with SEC
12:00am
SEC STAFF LETTER
u75f0y1
26 Sep 22
SEC staff letter
12:00am